Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: The role of D2 receptor activation

Journal of Pharmacology and Experimental Therapeutics

Volumn 328, Issue 3, 2009, Pages 807-812

  Farnsworth, Sarah J ^a   Volz, Trent J ^a   Hanson, Glen R ^a   Fleckenstein, Annette E ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DOPAMINE; DOPAMINE 2 RECEPTOR; ETICLOPRIDE; POTASSIUM ION; SODIUM CHLORIDE; VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; CYTOPLASM VESICLE; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL MEMBRANE; COCAINE; CORPUS STRIATUM; DOPAMINE; ELECTRIC STIMULATION; MALE; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SYNAPTIC VESICLES; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 62449230959     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.146159     Document Type: Article

References (39)

1. Brown JM, Hanson GR, and Fleckenstein AE (2001) Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors. J Pharmacol Exp Ther 298:1150-1153.
2. Cadet JL and Brannock C (1998) Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 32:117-131.
3. Chapin DS, Lookingland KJ, and Moore KE (1986) Effects of lc mobile phase composition on retention times for biogenic amines, and their precursors and metabolites. Curr Sep 7:68-70.
4. Cubells JF, Rayport S, Rajendran G, and Sulzer D (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dap amine-dependent intracellular oxidative stress. J Neurosci 14:2260-2271.
5. 3H]dopamine from rat striata as a result of prior exposure to cocaine, nomifensine, or mazindol. Neurochem Res 5:345-349.
6. 3H]catecholamine from brain: effects of pre-exposure to catecholamine uptake inhibitors. J Pharmacol. Exp Ther 217:727-732.
7. Fleckenstein AE, Volz TJ, and Hanson GR (2008) Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications. Neuropjharmacology 56 (Suppl 1):133-138.
8. Hanson GR, Matsuda LA, and Gibb JW (1987) Effects of cocaine on methamphetamine-induced neurochemical changes: characterization of cocaine as a monoamine uptake blocker. J Pharmacol Exp Ther 242:507-513.
9. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
10. Jedynak JP, Ah SF, Haycock JW, and Hope BT (2002) Acute administration of cocaine regulates the phosphorylation of serine-19, -31 and -40 in tyrosine hydroxylase. J Neurochem 82:382-388.
11. Kavalali ET (2006) Synaptic vesicle reuse and its implications. Neuroscientist 12:57-66.
12. Klongpanichapak S, Govitrapong P, Sharma SK, and Ebadi M (2006) Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10. Neurochem, Res 31:303-311.
13. Kobayashi S, Conforti L, Zhu WH, Beitner-Johnson D, and Millhorn DE (1999) Role of the D2 dopamine receptor in molecular adaptation to chronic hypoxia in PC 12 cells. PflugersArch 438:750-759.
14. Liu G (2003) Presynaptic control of quantal size: kinetic mechanisms and implications for synaptic transmission and plasticity. Curr Opin Neurobiol 13:324-331.
15. Markowitz JS, DeVane CL, Pestreich LK, Patrick KS, and Muniz R (2006) A comprehensive in vitro screening of D-, L-, and DL-threo-methylphenidate: an exploratory study. J Child Adolesc Psychopharmacol 16:687-698.
16. McElvain JS and Schenk JO (1992) Blockade of dopamine autoreceptors by haloper-idol and the apparent dynamics of potassium-stimulated endogenous release of dopamine from and reuptake into striatal suspensions in the rat. Neuropharmacology 31:649-659.
17. O'Hara CM, Uhland-Smith A, O'Malley KL, and Todd RD (1996) Inhibition of dopamine synthesis by D2 and D3 but not D4 receptors. J Pharmacol Exp Ther 277:186-192.
18. Onali P, Olianas MC, and Bunse B (1988) Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes. Brain Res 456:302-309.
19. Pathos EN, Przedborski S, Davila V, Schmitz Y, and Sulzer D (1998) D2-like dopamine autoreceptor activation reduces quantal size in PC12 cells. J Neurosci 18: 5575-5585.
20. Pothos EN and Sulzer D (1998) Modulation of quantal dopamine release by psychostimulants. Ad.v Pharmacol 42:198-202.
21. Riddle EL, Hanson GR, and Fleckenstein AE (2007) Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2. Eur J Pharmacol 571:25-28.
22. Riddle EL, Topham MK, Haycock JW, Hanson GR, and Fleckenstein AE (2002) Differential trafficking of the vesicular monoamine trans porter-2 by methamphet-amine and cocaine. Eur J Pharmacol 449:71-74.
23. Ritz MC, Lamb RJ, Goldberg SR, and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223.
24. Sandoval V, Riddle EL, Hanson GR, and Fleckenstein AE (2002) Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors. J Neurosci 22:8705-8710.
25. Sandoval V, Riddle EL, Hanson GR, and Fleckenstein AE (2003) Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits. J Pharmacol Exp Ther 304:1181-1187.
26. Schenk JO (2002) The functioning neuronal transporter for dopamine: kinetic mechanisms and effects of amphetamines, cocaine and methylphenidate. Prog Drug Res 59:111-131.
27. Schenk JO, Wright C, and Bjorklund N (2005) Unraveling neuronal dopamine transporter mechanisms with rotating disk electrode voltammetry. J Neurosci Methods 143:41-47.
28. Schweri MM, Skolnick P, Rafferty MF, Rice KC, Janowsky AJ, and Paul SM (1985) [3H]Threo-(±)-methylphenidate binding to 3,4- dihydroxyphenylethylamine uptake sites in corpus striatum: correlation with the stimulant properties of Ritalinic acid esters. J Neurochem 45:1062-1070.
29. Sharkey J, Ritz MC, Schenden JA, Hanson RC, and Kuhar MJ (1988) Cocaine mhibits muscarinic cholinergic receptors in heart and brain. J Pharmacol Exp Ther 246:1048-1052.
30. Starke K, Gothert M, and Kilbinger H (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 69:864-989.
31. Sudhof TC (2000) The synaptic vesicle cycle revisited. Neuron 28:317-320.
32. Truong JG, Newman AH, Hanson GR, and Fleckenstein AE (2004) Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein. Eur J Pharmacol 504:27-32.
33. Venton BJ, Seipel AT, Phillips PE, Wetsel WC, Gitler D, Greengard P, Augustine GJ, and Wightman RM (2006) Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci 26:3206-3209.
34. Volz TJ, Hanson GR, and Fleckenstein AE (2006) Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetry. J Neurosci Methods 155:109-115.
35. Volz TJ, Farnsworth SJ, King JL, Riddle EL, Hanson GR, and Fleckenstein AE (2007a) Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles. J Pharmacol Exp Ther 323:738-745.
36. Volz TJ, Hanson GR, and Fleckenstein AE (2007b) The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits. J Neurochem 101:883-888.
37. Volz TJ, Farnsworth SJ, Rowley SD, Hanson GR, and Fleckenstein AE (2008) Metliylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptors. J Pharmacol Exp Ther 327:161-167.
38. Wayment HK, Deutsch H, Schweri MM, and Schenk JO (1999) Effects of methylphenidate analogues on ph en ethyl amine substrates for the striatal dopamine transporter: potential as amphetamine antagonists? J Neurochem 72:1266-1274.
39. Zhu WH, Conforti L, and Millhorn DE (1997) Expression of dopamine D2 receptor in PC-12 cells and regulation of membrane conductances by dopamine. Am J Physiol 273:C1143-C1150.